{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:47:36Z","timestamp":1791226056011,"version":"4.1.0"},"publisher-location":"Chichester, UK","reference-count":73,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd008876.pub2","type":"reference-entry","created":{"date-parts":[[2011,9,28]],"date-time":"2011-09-28T12:33:55Z","timestamp":1317213235000},"source":"Crossref","is-referenced-by-count":6,"title":["Pharmacologic treatment for memory disorder in multiple sclerosis"],"prefix":"10.1002","author":[{"given":"Dian","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilong","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,10,5]]},"reference":[{"issue":"9","key":"10.1002\/14651858.CD008876.pub2-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1212\/01.WNL.0000142989.09633.5A","article-title":"Donepezil improved memory in multiple sclerosis in a randomized clinical trial","volume":"63","author":"Krupp","year":"2004","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD008876.pub2-BIB2|cit2","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1177\/1352458506071213","article-title":"Ginkgo biloba for the improvement of cognitive performance in multiple sclerosis: a randomized, placebo-controlled trial","volume":"13","author":"Lovera","year":"2007","journal-title":"Multiple Sclerosis"},{"issue":"6","key":"10.1002\/14651858.CD008876.pub2-BIB3|cit3","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1177\/1352458510367662","article-title":"Memantine for cognitive impairment in multiple sclerosis: a randomized placebo-controlled trial","volume":"16","author":"Lovera","year":"2010","journal-title":"Mult Scler"},{"issue":"4","key":"10.1002\/14651858.CD008876.pub2-BIB4|cit4","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1017\/S0317167100009148","article-title":"Effects of rivastigmine on memory and cognition in multiple sclerosis","volume":"35","author":"Shaygannejad","year":"2008","journal-title":"Canadian Journal of Neurological Sciences"},{"issue":"1","key":"10.1002\/14651858.CD008876.pub2-BIB5|cit5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/WNF.0b013e3181633497","article-title":"Psychopathological and cognitive effects of therapeutic cannabinoids in multiple sclerosis: a double-blind, placebo controlled, crossover study","volume":"32","author":"Aragona","year":"2009","journal-title":"Clinical Neuropharmacology"},{"key":"10.1002\/14651858.CD008876.pub2-BIB6|cit6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3109\/13651509909024756","article-title":"Neuropsychiatric Assessment As a Secondary Outcome Measure in a Multiple Sclerosis Intravenous Immunoglobulin (IVIg) Trial","volume":"3","author":"Barak","year":"1999","journal-title":"International Journal of Psychiatry in Clinical Practice"},{"issue":"1","key":"10.1002\/14651858.CD008876.pub2-BIB7|cit7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000047940","article-title":"Effect of interferon-beta-1b on cognitive functions in multiple sclerosis","volume":"47","author":"Barak","year":"2002","journal-title":"European Neurology"},{"issue":"6","key":"10.1002\/14651858.CD008876.pub2-BIB8|cit8","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1007\/s00415-008-0760-7","article-title":"Effects of l-amphetamine sulfate on cognitive function in multiple sclerosis patients","volume":"255","author":"Benedict","year":"2008","journal-title":"Journal of Neurology"},{"issue":"6","key":"10.1002\/14651858.CD008876.pub2-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1212\/WNL.47.6.1457","article-title":"Treatment with oral 3,4 diaminopyridine improves leg strength in multiple sclerosis patients: results of a randomized, double-blind, placebo-controlled, crossover trial","volume":"47","author":"Bever","year":"1996","journal-title":"Neurology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD008876.pub2-BIB10|cit10","first-page":"S150","article-title":"Donepezile and cognitive impairment in multiple sclerosis: a double-blind pilot study","volume":"10","author":"Bosca","year":"2004","journal-title":"Multiple Sclerosis"},{"issue":"3","key":"10.1002\/14651858.CD008876.pub2-BIB11|cit11","first-page":"214","article-title":"Interferon-alpha2b recombinant improved the cognitive dysfunction in patients with relapsing remitting multiple sclerosis","volume":"37","author":"Cabrera-Gomez","year":"2003","journal-title":"Revista Neurologia"},{"issue":"1-2","key":"10.1002\/14651858.CD008876.pub2-BIB12|cit12","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jns.2005.08.021","article-title":"Effects of donepezil on memory and cognition in multiple sclerosis","volume":"245","author":"Christodoulou","year":"2006","journal-title":"Journal of Neurological Sciences"},{"issue":"6","key":"10.1002\/14651858.CD008876.pub2-BIB13|cit13","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1001\/archneur.1989.00520420096030","article-title":"Amantadine treatment of fatigue associated with multiple sclerosis","volume":"46","author":"Cohen","year":"1989","journal-title":"Archives of Neurology"},{"issue":"5","key":"10.1002\/14651858.CD008876.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1212\/WNL.59.5.679","article-title":"Benefit of interferon beta-1a on MSFC progression in secondary progressive MS","volume":"59","author":"Cohen","year":"2002","journal-title":"Neurology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD008876.pub2-BIB15|cit15","first-page":"S150","article-title":"Effects of donepezil in multiple sclerosis: a single-centre trial","volume":"10","author":"Decoo","year":"2004","journal-title":"Multiple Sclerosis"},{"key":"10.1002\/14651858.CD008876.pub2-BIB16|cit16","first-page":"289","article-title":"Low Dose (7.5 Mg) Oral Methotrexate Improves Neurophysiological Function in Patients With Chronic Progressive Multiple Sclerosis","volume":"36","author":"Fischer","year":"1994","journal-title":"Annals of Neurology"},{"issue":"6","key":"10.1002\/14651858.CD008876.pub2-BIB17|cit17","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/1531-8249(200012)48:6<885::AID-ANA9>3.0.CO;2-1","article-title":"Neuropsychological effects of interferon beta-1a in relapsing multiple sclerosis. Multiple Sclerosis Collaborative Research Group","volume":"48","author":"Fischer","year":"2000","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1002\/14651858.CD008876.pub2-BIB18|cit18","first-page":"457","article-title":"Cognitive dysfunction evaluation in multiple sclerosis patients treated with interferon beta-1b: an open-label prospective 1 year study","volume":"9","author":"Flechter","year":"2007","journal-title":"The Israel Medical Association Journal"},{"issue":"2","key":"10.1002\/14651858.CD008876.pub2-BIB19|cit19","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/archneur.1996.00550020101021","article-title":"The effects of amantadine and pemoline on cognitive functioning in multiple sclerosis","volume":"53","author":"Geisler","year":"1996","journal-title":"Archives of Neurology"},{"issue":"3","key":"10.1002\/14651858.CD008876.pub2-BIB20|cit20","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/00004714-200006000-00010","article-title":"A 12-week, open trial of donepezil hydrochloride in patients with multiple sclerosis and associated cognitive impairments","volume":"20","author":"Greene","year":"2000","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"1-2","key":"10.1002\/14651858.CD008876.pub2-BIB21|cit21","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jns.2008.08.025","article-title":"Single dose of methylphenidate improves cognitive performance in multiple sclerosis patients with impaired attention process","volume":"276","author":"Harel","year":"2009","journal-title":"Journal of Neurological Sciences"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD008876.pub2-BIB22|cit22","first-page":"A137","article-title":"Donepezil for the treatment of memory impairments in multiple sclerosis","volume":"52","author":"Krupp","year":"1999","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD008876.pub2-BIB23|cit23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10072-010-0412-4","article-title":"The effect of natalizumab on cognitive function in patients with relapsing-remitting multiple sclerosis: preliminary results of a 1-year follow-up study","volume":"32","author":"Mattioli","year":"2011","journal-title":"Neurological Sciences"},{"key":"10.1002\/14651858.CD008876.pub2-BIB24|cit24","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3109\/00207454.2010.511732","article-title":"Fatigue and Cognition in Patients With Relapsing Multiple Sclerosis Treated With Interferon Beta","volume":"120","author":"Melanson","year":"2010","journal-title":"International Journal of Neuroscience"},{"issue":"7","key":"10.1002\/14651858.CD008876.pub2-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s00415-009-5074-x","article-title":"The effects of L-amphetamine sulfate on cognition in MS patients: results of a randomized controlled trial","volume":"256","author":"Morrow","year":"2009","journal-title":"Journal of Neurology"},{"issue":"6","key":"10.1002\/14651858.CD008876.pub2-BIB26|cit26","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1600-0404.1998.tb05967.x","article-title":"Pulsed methylprednisolone induces a reversible impairment of memory in patients with relapsing-remitting multiple sclerosis","volume":"97","author":"Oliveri","year":"1998","journal-title":"Acta Neurologica Scandinavica"},{"issue":"2","key":"10.1002\/14651858.CD008876.pub2-BIB27|cit27","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/1756285608101379","article-title":"Subcutaneous Interferon Beta-1a Has a Positive Effect on Cognitive Performance in Mildly Disabled Patients with Relapsing-Remitting Multiple Sclerosis: 2-Year Results from the COGIMUS Study","volume":"2","author":"Patti","year":"2009","journal-title":"Therapeutic Advances in Neurological Disorders"},{"issue":"1","key":"10.1002\/14651858.CD008876.pub2-BIB28|cit28","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1177\/1352458509350309","article-title":"Effects of immunomodulatory treatment with subcutaneous interferon beta-1a on cognitive decline in mildly disabled patients with relapsing-remitting multiple sclerosis","volume":"16","author":"Patti","year":"2010","journal-title":"Multiple Sclerosis"},{"key":"10.1002\/14651858.CD008876.pub2-BIB29|cit29","first-page":"326","article-title":"The Effects of Interferon-Beta on Cognitive Function in Multiple Sclerosis","volume":"36","author":"Pliskin","year":"1994","journal-title":"Annals of Neurology"},{"issue":"6","key":"10.1002\/14651858.CD008876.pub2-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1212\/WNL.47.6.1463","article-title":"Improved delayed visual reproduction test performance in multiple sclerosis patients receiving interferon beta-1b","volume":"47","author":"Pliskin","year":"1996","journal-title":"Neurology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD008876.pub2-BIB31|cit31","first-page":"A99","article-title":"Effects of donepezil on cognitive function in patients with multiple sclerosis","volume":"56","author":"Rorie","year":"2001","journal-title":"Neurology"},{"issue":"6","key":"10.1002\/14651858.CD008876.pub2-BIB32|cit32","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1177\/135245850100700602","article-title":"Fatigue in progressive multiple sclerosis: results of a randomized, double-blind, placebo-controlled, crossover trial of oral 4-aminopyridine","volume":"7","author":"Rossini","year":"2001","journal-title":"Multiple Sclerosis"},{"issue":"1","key":"10.1002\/14651858.CD008876.pub2-BIB33|cit33","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1055\/s-2000-7966","article-title":"Amantadine influences cognitive processing in patients with multiple sclerosis","volume":"33","author":"Sailer","year":"2000","journal-title":"Pharmacopsychiatry"},{"issue":"1-2","key":"10.1002\/14651858.CD008876.pub2-BIB34|cit34","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jns.2007.01.070","article-title":"Cognitive function in relapsing multiple sclerosis: minimal changes in a 10-year clinical trial","volume":"255","author":"Schwid","year":"2007","journal-title":"Journal of Neurological Sciences"},{"issue":"3 Pt 1","key":"10.1002\/14651858.CD008876.pub2-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.2466\/pms.1998.86.3.1099","article-title":"Interferon beta 1-b in verbal memory functioning of patients with relapsing-remitting multiple sclerosis","volume":"86","author":"Selby","year":"1998","journal-title":"Perceptual and Motor Skills"},{"issue":"9","key":"10.1002\/14651858.CD008876.pub2-BIB36|cit36","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1212\/WNL.44.9.1701","article-title":"The effects of 4-aminopyridine on cognitive function in patients with multiple sclerosis: a pilot study","volume":"44","author":"Smits","year":"1994","journal-title":"Neurology"},{"issue":"11","key":"10.1002\/14651858.CD008876.pub2-BIB37|cit37","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1212\/01.WNL.0000163804.94163.91","article-title":"Reversible impaired memory induced by pulsed methylprednisolone in patients with MS","volume":"64","author":"Uttner","year":"2005","journal-title":"Neurology"},{"issue":"19","key":"10.1002\/14651858.CD008876.pub2-BIB38|cit38","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1212\/01.wnl.0000342388.73185.80","article-title":"Memantine induces reversible neurologic impairment in patients with MS","volume":"72","author":"Villoslada","year":"2009","journal-title":"Neurology"},{"issue":"4","key":"10.1002\/14651858.CD008876.pub2-BIB39|cit39","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1191\/1352458504ms1082oa","article-title":"Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients","volume":"10","author":"Wade","year":"2004","journal-title":"Multiple Sclerosis"},{"issue":"3","key":"10.1002\/14651858.CD008876.pub2-BIB40|cit40","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1001\/archneur.56.3.319","article-title":"Neuropsychologic status in multiple sclerosis after treatment with glatiramer","volume":"56","author":"Weinstein","year":"1999","journal-title":"Archives of Neurology"},{"issue":"3","key":"10.1002\/14651858.CD008876.pub2-BIB41|cit41","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1191\/1352458505ms1172sr","article-title":"One-year cyclophosphamide treatment combined with methylprednisolone improves cognitive dysfunction in progressive forms of multiple sclerosis","volume":"11","author":"Z\u00e9phir","year":"2005","journal-title":"Multiple Sclerosis"},{"issue":"1","key":"10.1002\/14651858.CD008876.pub2-BIB42|cit42","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.neurol.2007.08.003","article-title":"Cognitive impact of mitoxantrone and methylprednisolone in multiple sclerosis: an open label study","volume":"164","author":"Z\u00e9phir","year":"2008","journal-title":"Revue Neurologique (Paris)"},{"key":"10.1002\/14651858.CD008876.pub2-BIB43|cit43","unstructured":"Trial of Ginkgo As a Treatment for Cognitive Problems in Multiple Sclerosis Ongoing study"},{"key":"10.1002\/14651858.CD008876.pub2-BIB44|cit44","unstructured":"Rivastigmine in Multiple Sclerosis Patients With Cognitive Impairment (EXCITING) Ongoing study"},{"key":"10.1002\/14651858.CD008876.pub2-BIB45|cit45","unstructured":"Study on Cognitive Disorders of Multiple Sclerosis Ongoing study"},{"key":"10.1002\/14651858.CD008876.pub2-BIB46|cit46","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1007\/s00018-003-3080-1","article-title":"Neuroprotective effects of Ginkgo biloba extract","volume":"60","author":"Ahlemeyer","year":"2003","journal-title":"Cellular Molecular Life Sciences"},{"issue":"10","key":"10.1002\/14651858.CD008876.pub2-BIB47|cit47","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1001\/archneur.58.10.1602","article-title":"Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years","volume":"58","author":"Amato","year":"2001","journal-title":"Archives of Neurology"},{"issue":"1-2","key":"10.1002\/14651858.CD008876.pub2-BIB48|cit48","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jns.2005.07.017","article-title":"Are there protective treatments for cognitive decline in MS?","volume":"245","author":"Amato","year":"2006","journal-title":"Journal of the Neurological Sciences"},{"issue":"3","key":"10.1002\/14651858.CD008876.pub2-BIB49|cit49","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1191\/1352458503ms904oa","article-title":"Fatigue associated with multiple sclerosis: diagnosis, impact and management","volume":"9","author":"Bakshi","year":"2003","journal-title":"Multiple Sclerosis"},{"key":"10.1002\/14651858.CD008876.pub2-BIB50|cit50","volume-title":"Brief Visuospatial Memory Test-Revised: Professional manual","author":"Benedict","year":"1997"},{"key":"10.1002\/14651858.CD008876.pub2-BIB51|cit51","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1212\/WNL.24.11.1019","article-title":"Evaluating storage, retention and retrieval in disordered memory and learning","volume":"24","author":"Buschke","year":"1974","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD008876.pub2-BIB52|cit52","volume-title":"California Verbal Learning Test","author":"Delis","year":"2000"},{"key":"10.1002\/14651858.CD008876.pub2-BIB53|cit53","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009] The Cochrane Collaboration"},{"key":"10.1002\/14651858.CD008876.pub2-BIB54|cit54","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejphar.2004.04.051","article-title":"Ginkgolides, diterpene trilactones ofGinkgo biloba, as antagonists at recombinant alpha1beta2gamma2LGABAA receptors","volume":"494","author":"Huang","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1002\/14651858.CD008876.pub2-BIB55|cit55","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1523\/JNEUROSCI.15-02-01308.1995","article-title":"Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine","volume":"15","author":"Kuczenski","year":"1995","journal-title":"The Journal of Neuroscience"},{"key":"10.1002\/14651858.CD008876.pub2-BIB56|cit56","volume-title":"Neuropsychological Assessment","author":"Lezak","year":"2004"},{"issue":"1","key":"10.1002\/14651858.CD008876.pub2-BIB57|cit57","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis","volume":"50","author":"McDonald","year":"2001","journal-title":"Annals of Neurology"},{"key":"10.1002\/14651858.CD008876.pub2-BIB58|cit58","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1054\/mehy.2000.1099","article-title":"Can the cognitive enhancing effects of Ginkgo biloba be explained by its pharmacology?","volume":"55","author":"Nathan","year":"2000","journal-title":"MedHypotheses"},{"issue":"2","key":"10.1002\/14651858.CD008876.pub2-BIB59|cit59","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1006\/nimg.1996.0032","article-title":"Functional basis of memory impairment in multiple sclerosis: a [18F] FDG PET study","volume":"4","author":"Paulesu","year":"1996","journal-title":"Neuroimage"},{"key":"10.1002\/14651858.CD008876.pub2-BIB60|cit60","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/71555","article-title":"Glutamate excitotoxicity in a model of multiple sclerosis","volume":"6(1)","author":"Pitt","year":"2000","journal-title":"Nature Medicine"},{"issue":"6","key":"10.1002\/14651858.CD008876.pub2-BIB61|cit61","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ana.20703","article-title":"Diagnostic criteria for multiple sclerosis: 2005 revisions to the \"McDonald Criteria\"","volume":"58","author":"Polman","year":"2005","journal-title":"Annals of Neurology"},{"issue":"3","key":"10.1002\/14651858.CD008876.pub2-BIB62|cit62","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ana.410130302","article-title":"New diagnostic criteria for multiple sclerosis: guidelines for research protocols","volume":"13","author":"Poser","year":"1983","journal-title":"Annals of Neurology"},{"key":"10.1002\/14651858.CD008876.pub2-BIB63|cit63","volume-title":"Cognitive Function Study Group, NMSS. A manual for the brief repeatable battery of neuropsychological tests in multiple sclerosis","author":"Rao","year":"1990"},{"key":"10.1002\/14651858.CD008876.pub2-BIB64|cit64","volume-title":"in collaboration with the Cognitive Function Study Group of the National Multiple Sclerosis Society. A manual for the brief, repeatable battery of neuropsychological tests in multiple sclerosis","author":"Rao","year":"1990"},{"key":"10.1002\/14651858.CD008876.pub2-BIB65|cit65","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1212\/WNL.41.5.692","article-title":"Cognitive dysfunction in multiple sclerosis: II. Impact on employment and social functioning","volume":"41","author":"Rao","year":"1991","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD008876.pub2-BIB66|cit66","volume-title":"Neuropsychological screening battery for multiple sclerosis","author":"Rao","year":"1991"},{"issue":"3","key":"10.1002\/14651858.CD008876.pub2-BIB67|cit67","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1037\/0894-4105.7.3.364","article-title":"Memory dysfunction in multiple sclerosis:its relation to working memory, semantic encoding, and implicit learning","volume":"7","author":"Rao","year":"1993","journal-title":"Neuropsychology"},{"key":"10.1002\/14651858.CD008876.pub2-BIB68|cit68","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2008"},{"issue":"5","key":"10.1002\/14651858.CD008876.pub2-BIB69|cit69","doi-asserted-by":"crossref","first-page":"538-43","DOI":"10.1136\/jnnp.50.5.538","article-title":"Acetylcholinesterase and butyrylcholinesterase activity in the cerebrospinal fluid of patients with neurodegenerative diseases involving cholinergic systems","volume":"50","author":"Ruberg","year":"1987","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1002\/14651858.CD008876.pub2-BIB70|cit70","volume-title":"Symbol Digit Modalities Test (SDMT)","author":"Smith","year":"1982"},{"key":"10.1002\/14651858.CD008876.pub2-BIB71|cit71","volume-title":"Wechsler Memory Scale-Revised","author":"Wechsler","year":"1987"},{"key":"10.1002\/14651858.CD008876.pub2-BIB72|cit72","volume-title":"Wechsler Memory Scale-Third Edition (WMS---III)","author":"Wechsler","year":"1997"},{"key":"10.1002\/14651858.CD008876.pub2-BIB73|cit73","volume-title":"Wechsler Adult Intelligence Scale","author":"Wechsler","year":"1997"}],"updated-by":[{"DOI":"10.1002\/14651858.cd008876.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2013,12,17]],"date-time":"2013-12-17T00:00:00Z","timestamp":1387238400000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD008876.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T20:51:35Z","timestamp":1638910295000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD008876.pub2"}},"subtitle":[],"editor":[{"given":"Hongyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,10,5]]},"references-count":73,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd008876.pub2","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD008876.pub3","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2011,10,5]]}}}